1. Home
  2. ETNB vs JJSF Comparison

ETNB vs JJSF Comparison

Compare ETNB & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • JJSF
  • Stock Information
  • Founded
  • ETNB 2018
  • JJSF 1971
  • Country
  • ETNB United States
  • JJSF United States
  • Employees
  • ETNB 93
  • JJSF N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • JJSF Specialty Foods
  • Sector
  • ETNB Health Care
  • JJSF Consumer Staples
  • Exchange
  • ETNB Nasdaq
  • JJSF Nasdaq
  • Market Cap
  • ETNB 2.2B
  • JJSF 1.9B
  • IPO Year
  • ETNB 2019
  • JJSF N/A
  • Fundamental
  • Price
  • ETNB $14.83
  • JJSF $95.37
  • Analyst Decision
  • ETNB Buy
  • JJSF Buy
  • Analyst Count
  • ETNB 10
  • JJSF 2
  • Target Price
  • ETNB $22.31
  • JJSF $142.50
  • AVG Volume (30 Days)
  • ETNB 9.5M
  • JJSF 196.6K
  • Earning Date
  • ETNB 11-06-2025
  • JJSF 11-12-2025
  • Dividend Yield
  • ETNB N/A
  • JJSF 3.26%
  • EPS Growth
  • ETNB N/A
  • JJSF N/A
  • EPS
  • ETNB N/A
  • JJSF 4.29
  • Revenue
  • ETNB N/A
  • JJSF $1,599,746,000.00
  • Revenue This Year
  • ETNB N/A
  • JJSF $3.57
  • Revenue Next Year
  • ETNB N/A
  • JJSF $2.70
  • P/E Ratio
  • ETNB N/A
  • JJSF $22.29
  • Revenue Growth
  • ETNB N/A
  • JJSF 0.49
  • 52 Week Low
  • ETNB $4.16
  • JJSF $94.13
  • 52 Week High
  • ETNB $15.06
  • JJSF $180.80
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 79.17
  • JJSF 30.98
  • Support Level
  • ETNB $14.67
  • JJSF $94.13
  • Resistance Level
  • ETNB $14.93
  • JJSF $99.14
  • Average True Range (ATR)
  • ETNB 0.09
  • JJSF 2.18
  • MACD
  • ETNB 0.06
  • JJSF 0.12
  • Stochastic Oscillator
  • ETNB 41.03
  • JJSF 16.13

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

Share on Social Networks: